Sands Capital Life Sciences Pulse Fund II L.P. 13D and 13G filings for Beta Bionics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 11:20 am Purchase | 2025-06-30 | 13G | Beta Bionics, Inc. BBNX | Sands Capital Life Sciences Pulse Fund II L.P. | 3,570,113 8.200% | 415,704 (+13.18%) | Filing |
| 2025-04-09 4:10 pm Purchase | 2025-04-02 | 13G | Beta Bionics, Inc. BBNX | Sands Capital Life Sciences Pulse Fund II L.P. | 3,154,409 7.300% | 3,154,409 (New Position) | Filing |